← Back to patent-cliff list
CAS 4334-88-7
4-(Ethoxycarbonyl)phenylboronic acid(4-(ethoxycarbonyl)phenyl)boronic acid
Codes: (XI)91299-1-b, MOME-002, ETC-206-004
Application context (from source-drug indications)
Plasmodium infectionArtesunate/Pyronaridine PhosphateCOVID-19Artesunate/Pyronaridine PhosphateFalciparum malariaArtesunate/Pyronaridine PhosphatePlasmodium infectionArtesunate/Mefloquine HydrochlorideFalciparum malariaArtesunate/Mefloquine HydrochloridePlasmodium infectionArtesunateIntestinal neoplasmArtesunateColon cancerArtesunateCervical intraepithelial neoplasiaArtesunateHIV infectionArtesunateCervical cancerArtesunateMyelofibrosisMomelotinib DihydrochlorideMyeloproliferative neoplasmMomelotinib DihydrochlorideSplenomegalyMomelotinib DihydrochlorideAnaemiaMomelotinib DihydrochlorideVEXAS综合征Momelotinib DihydrochlorideEssential thrombocythaemiaMomelotinib DihydrochlorideColorectal cancerTinodasertib
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Artesunate/Pyronaridine Phosphate | Tier C — Watch / trade | - |
| Artesunate/Mefloquine Hydrochloride | Tier C — Watch / trade | - |
| Artesunate | Tier C — Watch / trade | - |
| Momelotinib Dihydrochloride | Tier C — Watch / trade | - |
| Tinodasertib | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1,4-Bis(trifluoromethyl)benzene→1,4-Dibromo-2,5-bis(trifluoromethyl)benzene→(4-Hydroxyphenyl)boronic acid→2(2),2(5)-Bis(trifluoromethyl)[1(1),2(1):2(4),3(1)-terphenyl]-1(4),3(4)-diol→1(3),1(5),3(3),3(5)-Tetrabromo-2(2),2(5)-bis(trifluoromethyl)[1(1),2(1):2(4),3(1)-terphenyl]-1(4),3(4)-diol→1(3),1(5),3(3),3(5)-Tetrabromo-1(4),3(4)-dimethoxy-2(2),2(5)-bis(trifluoromethyl)-1(1),2(1):2(4),3(1)-terphenyl→4-(Ethoxycarbonyl)phenylboronic acid→Ethyl 4-[5-[4-[3,5-bis(4-ethoxycarbonylphenyl)-4-methoxy-phenyl]-2,5-bis(trifluoromethyl)phenyl]-3-(4-ethoxycarbonylphenyl)-2-methoxy-phenyl]benzoate→4-[5-[4-[3,5-Bis(4-carboxyphenyl)-4-methoxy-phenyl]-2,5-bis(trifluoromethyl)phenyl]-3-(4-carboxyphenyl)-2-methoxy-phenyl]benzoic acid
1,4-Bis(trifluoromethyl)benzene→1,4-Dibromo-2,5-bis(trifluoromethyl)benzene→(4-Hydroxyphenyl)boronic acid→2(2),2(5)-Bis(trifluoromethyl)[1(1),2(1):2(4),3(1)-terphenyl]-1(4),3(4)-diol→1(3),1(5),3(3),3(5)-Tetrabromo-2(2),2(5)-bis(trifluoromethyl)[1(1),2(1):2(4),3(1)-terphenyl]-1(4),3(4)-diol→1(3),1(5),3(3),3(5)-Tetrabromo-1(4),3(4)-dimethoxy-2(2),2(5)-bis(trifluoromethyl)-1(1),2(1):2(4),3(1)-terphenyl→4-(Ethoxycarbonyl)phenylboronic acid→Ethyl 4-[5-[4-[3,5-bis(4-ethoxycarbonylphenyl)-4-methoxy-phenyl]-2,5-bis(trifluoromethyl)phenyl]-3-(4-ethoxycarbonylphenyl)-2-methoxy-phenyl]benzoate→4-[5-[4-[3,5-Bis(4-carboxyphenyl)-4-methoxy-phenyl]-2,5-bis(trifluoromethyl)phenyl]-3-(4-carboxyphenyl)-2-methoxy-phenyl]benzoic acid
1,4-Bis(trifluoromethyl)benzene→1,4-Dibromo-2,5-bis(trifluoromethyl)benzene→(4-Hydroxyphenyl)boronic acid→2(2),2(5)-Bis(trifluoromethyl)[1(1),2(1):2(4),3(1)-terphenyl]-1(4),3(4)-diol→1(3),1(5),3(3),3(5)-Tetrabromo-2(2),2(5)-bis(trifluoromethyl)[1(1),2(1):2(4),3(1)-terphenyl]-1(4),3(4)-diol→1(3),1(5),3(3),3(5)-Tetrabromo-1(4),3(4)-dimethoxy-2(2),2(5)-bis(trifluoromethyl)-1(1),2(1):2(4),3(1)-terphenyl→4-(Ethoxycarbonyl)phenylboronic acid→Ethyl 4-[5-[4-[3,5-bis(4-ethoxycarbonylphenyl)-4-methoxy-phenyl]-2,5-bis(trifluoromethyl)phenyl]-3-(4-ethoxycarbonylphenyl)-2-methoxy-phenyl]benzoate→4-[5-[4-[3,5-Bis(4-carboxyphenyl)-4-methoxy-phenyl]-2,5-bis(trifluoromethyl)phenyl]-3-(4-carboxyphenyl)-2-methoxy-phenyl]benzoic acid
4-(6-(4-(morpholine-4-carbonyl)phenyl)imidazo[1,2-a]pyridin-3-yl)benzonitrile→6-bromo-3-iodoimidazo[1,2-a]pyridine→(4-cyanophenyl)boronic acid→4-(6-bromoimidazo[1,2-a]pyridin-3-yl)benzonitrile→(4-(ethoxycarbonyl)phenyl)boronic acid→ethyl 4-(3-(4-cyanophenyl)imidazo[1,2-a]pyridin-6-yl)benzoate→4-(3-(4-cyanophenyl)imidazo[1,2-a]pyridin-6-yl)benzoic acid
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.